on a mobile?
 
vTap
    Loading...
 
 
Video
Japanese drug maker Daiichi Sankyo has put in a $4.6 billion bid to acquire a majority stake in India's largest drug maker, Ranbaxy. Aadil E...
5m 4s |
5 months ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Daiichi Sankyo Co.
Go to Feed to see what's new!
share
keep
 
 
585
Masaya Tamae of Daiichi Sankyo said Ranbaxy's product pipeline and geographical presence is attractive. Tamae told CNBC-TV18 that they will explore other options if the 20% open offer does not happen....
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daiichi Sankyo Co.
CNBC-TV18
CNBC
Go to Feed to see what's new!
share
keep
 
 
5235
Daiichi Sankyo will buy out the entire promoter stake of 35% in Ranbaxy Labs at Rs 737/sh, which will also be priced at Rs 737 per share, reports CNBC-TV18. Daiichi's stake buy in Ranbaxy will ...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daiichi Sankyo Co.
CNBC-TV18
CNBC
Go to Feed to see what's new!
share
keep
 
 
5 months ago
NDTV.COM
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
Existing management to continue under CEO and MD, Malvinder Singh.
5 months ago
CNN-IBN (India)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
Rhenu Bhuller, pharmaceutical analyst at Frost & Sullivan, talks with Bloomberg's Bernard Lo from Singapore about Daiichi Sankyo Co.'s purchase of Ranbaxy Laboratories Ltd., the role of generic medicines in treating diseases and drug development in emerging markets. Japanese drugmaker Daiichi Sankyo said it would buy a controlling stake in India's Ranbaxy for as much as $4.6 billion to enter the generic drug market. (Source: Bloomberg)
5 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Daiichi Sankyo Co.
Pharmaceutical company
Drug development
Theta role
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums
Privacy Policy and Terms of Use